We put longevity biotech in front of the capital that backs it.
Transactions built on the most comprehensive database of biotech companies building the longevity economy. We work with pharma business development teams, institutional and private investors, and founders raising their next round.
WAYS TO WORK WITH US
01
BD, VC and PE partnering on investment deals
02
Investor Club membership for professional and qualified investors
03
Investor introductions for companies raising capital
Who we work with
DEAL FLOW
Pharma BD teams, VCs and PE
We activate deal flow from biotechs at different growth stages: tell us your investment thesis and we’ll share relevant DLT intelligence.
SPV SYNDICATE
Family offices and private investors
Join the Investor Club waitlist. Eligibility checks and onboarding are handled by Odin.
RAISING CAPITAL
Founders raising your next round
We're here to help you raise capital from the right investors.
The market we are central to:
$30bn+
Invested in 2025/26 - we track the transactions and understand the investment opportunities
25
Longevity domains tracked, senotherapeutics to partial reprogramming
780+
We track all of the SMID-biotech longevity companies
10 years
Of public and private market data, by location, domain and stage
Let's Talk
Tell us what you are looking for and one of the team members will reply ASAP. Nothing you send here is shared with third parties.
Investment Form
This page is not an invitation or inducement to engage in investment activity